 Mark Erickson
Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 47 | 2025 | 203 | 8.120 |
Why?
| | Spinal Fusion | 39 | 2024 | 230 | 7.410 |
Why?
| | Surgical Wound Infection | 9 | 2022 | 283 | 1.740 |
Why?
| | Thoracic Vertebrae | 14 | 2024 | 74 | 1.720 |
Why?
| | Internal Fixators | 5 | 2015 | 34 | 1.390 |
Why?
| | Kyphosis | 8 | 2024 | 36 | 1.320 |
Why?
| | Bone Screws | 8 | 2024 | 112 | 1.270 |
Why?
| | Spine | 11 | 2022 | 158 | 1.260 |
Why?
| | Lumbar Vertebrae | 6 | 2015 | 231 | 1.160 |
Why?
| | Radiography | 14 | 2024 | 798 | 1.060 |
Why?
| | Pain, Postoperative | 4 | 2017 | 233 | 0.970 |
Why?
| | Musculoskeletal Diseases | 2 | 2019 | 69 | 0.740 |
Why?
| | Postoperative Complications | 10 | 2024 | 2483 | 0.700 |
Why?
| | Neuromuscular Diseases | 4 | 2025 | 105 | 0.680 |
Why?
| | Fitness Trackers | 1 | 2019 | 9 | 0.660 |
Why?
| | Musculoskeletal System | 1 | 2019 | 46 | 0.630 |
Why?
| | Child | 42 | 2025 | 20882 | 0.620 |
Why?
| | Follow-Up Studies | 12 | 2025 | 4896 | 0.580 |
Why?
| | Retrospective Studies | 33 | 2025 | 14519 | 0.580 |
Why?
| | Patient Care Team | 3 | 2012 | 605 | 0.570 |
Why?
| | Vancomycin | 1 | 2018 | 78 | 0.570 |
Why?
| | Treatment Outcome | 26 | 2025 | 10226 | 0.560 |
Why?
| | Orthopedics | 1 | 2019 | 135 | 0.550 |
Why?
| | Quality of Life | 8 | 2025 | 2704 | 0.550 |
Why?
| | Adolescent | 35 | 2025 | 20391 | 0.550 |
Why?
| | Spinal Diseases | 2 | 2017 | 48 | 0.510 |
Why?
| | Reoperation | 2 | 2016 | 545 | 0.500 |
Why?
| | Propionibacterium acnes | 1 | 2015 | 10 | 0.480 |
Why?
| | Intervertebral Disc | 1 | 2015 | 39 | 0.470 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 48 | 0.450 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2015 | 67 | 0.450 |
Why?
| | Prosthesis-Related Infections | 1 | 2015 | 75 | 0.450 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 393 | 0.430 |
Why?
| | Sutures | 1 | 2013 | 52 | 0.430 |
Why?
| | Humans | 68 | 2025 | 129622 | 0.420 |
Why?
| | Home Nursing | 1 | 2013 | 26 | 0.420 |
Why?
| | Suture Techniques | 1 | 2013 | 118 | 0.410 |
Why?
| | Patient Satisfaction | 3 | 2025 | 633 | 0.400 |
Why?
| | Casts, Surgical | 1 | 2012 | 26 | 0.400 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 19 | 0.400 |
Why?
| | Bupivacaine | 1 | 2012 | 30 | 0.400 |
Why?
| | Equipment Failure | 1 | 2013 | 107 | 0.390 |
Why?
| | Soft Tissue Injuries | 1 | 2013 | 39 | 0.390 |
Why?
| | Amides | 1 | 2012 | 91 | 0.380 |
Why?
| | Humeral Fractures | 1 | 2012 | 48 | 0.380 |
Why?
| | Fracture Fixation | 1 | 2012 | 78 | 0.380 |
Why?
| | Preoperative Care | 2 | 2011 | 340 | 0.380 |
Why?
| | Metals | 1 | 2013 | 128 | 0.380 |
Why?
| | Male | 40 | 2025 | 63674 | 0.380 |
Why?
| | Orthopedic Procedures | 2 | 2018 | 210 | 0.350 |
Why?
| | Female | 41 | 2025 | 68770 | 0.350 |
Why?
| | Bone Nails | 2 | 2012 | 64 | 0.320 |
Why?
| | Blood Loss, Surgical | 2 | 2021 | 93 | 0.310 |
Why?
| | Diskectomy | 1 | 2007 | 21 | 0.280 |
Why?
| | Caregivers | 2 | 2022 | 815 | 0.280 |
Why?
| | Decompression, Surgical | 2 | 2007 | 99 | 0.280 |
Why?
| | Anti-Bacterial Agents | 4 | 2018 | 1717 | 0.270 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2007 | 58 | 0.270 |
Why?
| | Cervical Vertebrae | 1 | 2007 | 133 | 0.250 |
Why?
| | Hospitals, Pediatric | 5 | 2017 | 509 | 0.230 |
Why?
| | Prospective Studies | 13 | 2023 | 7131 | 0.230 |
Why?
| | Ribs | 1 | 2024 | 33 | 0.230 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2024 | 21 | 0.220 |
Why?
| | Pedicle Screws | 1 | 2024 | 18 | 0.220 |
Why?
| | Practice Guidelines as Topic | 4 | 2017 | 1501 | 0.210 |
Why?
| | Algorithms | 1 | 2010 | 1622 | 0.200 |
Why?
| | Risk Factors | 8 | 2018 | 9763 | 0.200 |
Why?
| | Osteotomy | 4 | 2023 | 99 | 0.200 |
Why?
| | Cohort Studies | 5 | 2023 | 5420 | 0.200 |
Why?
| | Robotic Surgical Procedures | 1 | 2024 | 115 | 0.190 |
Why?
| | Muscle Relaxants, Central | 1 | 2022 | 11 | 0.190 |
Why?
| | Child, Preschool | 8 | 2025 | 10518 | 0.190 |
Why?
| | Pain | 3 | 2024 | 789 | 0.190 |
Why?
| | Neural Tube Defects | 1 | 2022 | 62 | 0.190 |
Why?
| | Laminectomy | 1 | 2021 | 29 | 0.180 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 11 | 0.180 |
Why?
| | Pelvic Bones | 1 | 2004 | 156 | 0.180 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 372 | 0.180 |
Why?
| | Postoperative Care | 2 | 2015 | 240 | 0.180 |
Why?
| | Pain Measurement | 3 | 2017 | 506 | 0.180 |
Why?
| | Thoracoplasty | 1 | 2020 | 2 | 0.180 |
Why?
| | Length of Stay | 4 | 2017 | 1127 | 0.170 |
Why?
| | Scheuermann Disease | 1 | 2019 | 1 | 0.160 |
Why?
| | Parents | 2 | 2020 | 1309 | 0.160 |
Why?
| | Analgesics, Opioid | 2 | 2017 | 913 | 0.160 |
Why?
| | Surveys and Questionnaires | 8 | 2025 | 5401 | 0.160 |
Why?
| | Bone Wires | 2 | 2011 | 18 | 0.150 |
Why?
| | Mental Health | 1 | 2025 | 686 | 0.150 |
Why?
| | Administration, Topical | 1 | 2018 | 145 | 0.150 |
Why?
| | Patient Preference | 1 | 2020 | 185 | 0.150 |
Why?
| | Incidence | 3 | 2019 | 2644 | 0.140 |
Why?
| | Osteogenesis Imperfecta | 1 | 2017 | 13 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2019 | 180 | 0.140 |
Why?
| | Drug Utilization Review | 1 | 2017 | 57 | 0.140 |
Why?
| | Surgeons | 1 | 2021 | 261 | 0.140 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 101 | 0.140 |
Why?
| | Clinical Protocols | 1 | 2018 | 255 | 0.130 |
Why?
| | Patient Participation | 1 | 2020 | 413 | 0.130 |
Why?
| | Morphine | 1 | 2017 | 137 | 0.130 |
Why?
| | Comorbidity | 2 | 2011 | 1547 | 0.120 |
Why?
| | Age of Onset | 2 | 2018 | 496 | 0.120 |
Why?
| | Radiologic Health | 1 | 2015 | 4 | 0.120 |
Why?
| | Debridement | 1 | 2015 | 83 | 0.120 |
Why?
| | Fluoroscopy | 1 | 2015 | 156 | 0.120 |
Why?
| | Blood Transfusion | 1 | 2017 | 296 | 0.120 |
Why?
| | Informed Consent | 1 | 2016 | 170 | 0.110 |
Why?
| | Cost Savings | 1 | 2015 | 78 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 857 | 0.110 |
Why?
| | Equipment Failure Analysis | 1 | 2015 | 131 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 516 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1367 | 0.110 |
Why?
| | Patient Readmission | 2 | 2017 | 667 | 0.110 |
Why?
| | Pain Management | 1 | 2017 | 327 | 0.110 |
Why?
| | Patient Compliance | 1 | 2018 | 565 | 0.110 |
Why?
| | Device Removal | 1 | 2015 | 136 | 0.110 |
Why?
| | Hospital Charges | 1 | 2013 | 41 | 0.110 |
Why?
| | Guideline Adherence | 1 | 2017 | 526 | 0.100 |
Why?
| | Asepsis | 1 | 2013 | 2 | 0.100 |
Why?
| | Syringomyelia | 2 | 2003 | 12 | 0.100 |
Why?
| | Drug Administration Schedule | 2 | 2012 | 769 | 0.100 |
Why?
| | Osteolysis | 1 | 2013 | 18 | 0.100 |
Why?
| | Off-Label Use | 1 | 2013 | 51 | 0.100 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 46 | 0.100 |
Why?
| | Quality Improvement | 3 | 2018 | 1101 | 0.100 |
Why?
| | United States | 6 | 2020 | 13900 | 0.100 |
Why?
| | Anesthetics, Local | 1 | 2012 | 75 | 0.100 |
Why?
| | Risk Assessment | 2 | 2012 | 3240 | 0.100 |
Why?
| | Single-Blind Method | 1 | 2012 | 271 | 0.090 |
Why?
| | Pelvis | 2 | 2024 | 104 | 0.090 |
Why?
| | Intraoperative Period | 1 | 2011 | 53 | 0.090 |
Why?
| | Elective Surgical Procedures | 1 | 2012 | 165 | 0.090 |
Why?
| | Reproducibility of Results | 4 | 2021 | 3083 | 0.090 |
Why?
| | Injury Severity Score | 1 | 2012 | 509 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2012 | 1288 | 0.080 |
Why?
| | Dibenzothiazepines | 1 | 2009 | 17 | 0.080 |
Why?
| | Nerve Growth Factor | 1 | 2009 | 27 | 0.080 |
Why?
| | Psychomotor Agitation | 1 | 2009 | 64 | 0.080 |
Why?
| | Interprofessional Relations | 1 | 2011 | 276 | 0.080 |
Why?
| | Edema | 1 | 2009 | 124 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2012 | 0.070 |
Why?
| | Spinal Stenosis | 1 | 2007 | 27 | 0.070 |
Why?
| | Radiculopathy | 1 | 2007 | 33 | 0.070 |
Why?
| | Delphi Technique | 2 | 2022 | 224 | 0.070 |
Why?
| | Intervertebral Disc Displacement | 1 | 2007 | 39 | 0.070 |
Why?
| | Antipsychotic Agents | 1 | 2009 | 195 | 0.070 |
Why?
| | Patient Discharge | 1 | 2013 | 857 | 0.070 |
Why?
| | Bipolar Disorder | 1 | 2009 | 235 | 0.070 |
Why?
| | Prostheses and Implants | 1 | 2007 | 133 | 0.060 |
Why?
| | Qualitative Research | 1 | 2013 | 1234 | 0.060 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 366 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2742 | 0.060 |
Why?
| | Consensus | 2 | 2022 | 615 | 0.060 |
Why?
| | Prevalence | 2 | 2013 | 2564 | 0.060 |
Why?
| | Critical Care | 1 | 2010 | 553 | 0.060 |
Why?
| | Biomechanical Phenomena | 2 | 2008 | 764 | 0.060 |
Why?
| | Recovery of Function | 2 | 2024 | 642 | 0.060 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2025 | 22 | 0.060 |
Why?
| | Hypotension, Orthostatic | 1 | 2004 | 7 | 0.060 |
Why?
| | Metatarsus | 1 | 2004 | 2 | 0.060 |
Why?
| | Hallux Valgus | 1 | 2004 | 9 | 0.060 |
Why?
| | Outpatients | 1 | 2007 | 370 | 0.060 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2004 | 85 | 0.050 |
Why?
| | Lung | 2 | 2020 | 3931 | 0.050 |
Why?
| | Spinal Neoplasms | 1 | 2003 | 29 | 0.050 |
Why?
| | Patient Education as Topic | 2 | 2020 | 741 | 0.050 |
Why?
| | Intraoperative Complications | 1 | 2024 | 131 | 0.050 |
Why?
| | Cerebral Palsy | 1 | 2025 | 96 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2010 | 3381 | 0.050 |
Why?
| | Osteosarcoma | 1 | 2003 | 72 | 0.050 |
Why?
| | Arnold-Chiari Malformation | 1 | 2002 | 31 | 0.050 |
Why?
| | Baclofen | 1 | 2022 | 15 | 0.050 |
Why?
| | Infusion Pumps, Implantable | 1 | 2022 | 22 | 0.050 |
Why?
| | Neurosurgical Procedures | 1 | 2023 | 173 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2009 | 1706 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2011 | 3408 | 0.040 |
Why?
| | Spinal Cord Injuries | 1 | 2024 | 194 | 0.040 |
Why?
| | Infant | 2 | 2013 | 9025 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3144 | 0.040 |
Why?
| | Middle Aged | 5 | 2016 | 31150 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 286 | 0.040 |
Why?
| | Forced Expiratory Volume | 2 | 2012 | 511 | 0.040 |
Why?
| | Time Factors | 3 | 2017 | 6556 | 0.040 |
Why?
| | Depression | 1 | 2009 | 1307 | 0.040 |
Why?
| | Young Adult | 2 | 2013 | 12426 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2009 | 1614 | 0.040 |
Why?
| | Menarche | 1 | 2019 | 59 | 0.040 |
Why?
| | Disease Progression | 3 | 2019 | 2635 | 0.040 |
Why?
| | Pyomyositis | 1 | 2017 | 13 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2022 | 438 | 0.040 |
Why?
| | Bloodless Medical and Surgical Procedures | 1 | 2017 | 2 | 0.040 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2017 | 11 | 0.030 |
Why?
| | Braces | 1 | 2017 | 21 | 0.030 |
Why?
| | Risk Management | 1 | 2018 | 85 | 0.030 |
Why?
| | Ketorolac | 1 | 2017 | 21 | 0.030 |
Why?
| | Injections, Spinal | 1 | 2017 | 109 | 0.030 |
Why?
| | Adult | 4 | 2020 | 35572 | 0.030 |
Why?
| | Observer Variation | 1 | 2018 | 315 | 0.030 |
Why?
| | Diphosphonates | 1 | 2017 | 58 | 0.030 |
Why?
| | Central Venous Catheters | 1 | 2017 | 48 | 0.030 |
Why?
| | Organ Size | 1 | 2018 | 447 | 0.030 |
Why?
| | Abscess | 1 | 2017 | 73 | 0.030 |
Why?
| | Operative Time | 1 | 2017 | 124 | 0.030 |
Why?
| | Medical Records | 1 | 2017 | 171 | 0.030 |
Why?
| | Bone Density Conservation Agents | 1 | 2017 | 70 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2017 | 141 | 0.030 |
Why?
| | Arthritis, Infectious | 1 | 2017 | 60 | 0.030 |
Why?
| | Drug Utilization | 1 | 2017 | 171 | 0.030 |
Why?
| | Registries | 1 | 2024 | 1895 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2017 | 173 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 169 | 0.030 |
Why?
| | Postoperative Period | 1 | 2017 | 329 | 0.030 |
Why?
| | Fever | 1 | 2017 | 298 | 0.030 |
Why?
| | Perioperative Care | 1 | 2017 | 152 | 0.030 |
Why?
| | Self-Assessment | 1 | 2016 | 69 | 0.030 |
Why?
| | Osteomyelitis | 1 | 2017 | 122 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 1023 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2012 | 1206 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 980 | 0.030 |
Why?
| | Comprehension | 1 | 2016 | 165 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2017 | 608 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2017 | 1876 | 0.020 |
Why?
| | Drainage | 1 | 2012 | 165 | 0.020 |
Why?
| | Preoperative Period | 1 | 2011 | 115 | 0.020 |
Why?
| | Body Mass Index | 1 | 2019 | 2273 | 0.020 |
Why?
| | Vital Capacity | 1 | 2011 | 292 | 0.020 |
Why?
| | Health Care Costs | 1 | 2013 | 367 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5066 | 0.020 |
Why?
| | Quetiapine Fumarate | 1 | 2009 | 23 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2011 | 586 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 993 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4420 | 0.020 |
Why?
| | Cadaver | 1 | 2008 | 306 | 0.020 |
Why?
| | Databases, Factual | 1 | 2012 | 1269 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1838 | 0.020 |
Why?
| | Suicide, Attempted | 1 | 2009 | 349 | 0.020 |
Why?
| | Endpoint Determination | 1 | 2004 | 76 | 0.010 |
Why?
| | Lordosis | 1 | 2003 | 14 | 0.010 |
Why?
| | Mass Screening | 1 | 2011 | 1149 | 0.010 |
Why?
| | Survival | 1 | 2003 | 39 | 0.010 |
Why?
| | Stereotaxic Techniques | 1 | 2003 | 38 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2406 | 0.010 |
Why?
| | Morbidity | 1 | 2003 | 302 | 0.010 |
Why?
| | Cross-Over Studies | 1 | 2004 | 521 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5499 | 0.010 |
Why?
| | Pilot Projects | 1 | 2004 | 1587 | 0.010 |
Why?
| | Blood Pressure | 1 | 2004 | 1735 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 1565 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2003 | 2535 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2004 | 7084 | 0.010 |
Why?
| | Animals | 1 | 2009 | 35360 | 0.000 |
Why?
| | Aged | 1 | 2004 | 22099 | 0.000 |
Why?
|
|
Erickson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|